National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

incyclinide
A chemically-modified tetracycline with potential antineoplastic activity. Incyclinide inhibits matrix metalloproteinases (MMPs), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. This agent also causes mitochondrial depolarization in tumor cells and induces both cellular apoptosis and tissue necrosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Metastat
Code names:CMT-3
COL 3
Chemical structure names:
  • 4-dimethlyamino sancycline
  • 4-dimethlyaminosancycline
  • 6-deoxy, 6-demethyl, 4-de-dimethylamino tetracycline

Previous:Imuran, inalimarev, Inapsine, Incel, incomplete Freund's adjuvant
Next:indibulin, indicine-N-oxide, indinavir sulfate, indium I 111 bevacizumab, indium I 111 chimeric monoclonal antibody G250